Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT05824260
Eligibility Criteria:
Inclusion Criteria:
* Abdominal, orthopaedic or vascular surgery under general anaesthesia and with an estimated duration of surgery \> 2 hours
* Adult patients (age ≥ 18 years)
* ASA score ≥ II
* Patient with at least two of the following comorbidities: age \> 50 years, high blood pressure (HTA), heart failure, ECG abnormality, smoking, stroke, transient ischemic attack (TIA), peripheral arterial disease (PAD), insulin-dependent or non-insulin-dependent diabetes mellitus (NIDDM), ascites, chronic renal failure (CRF)
* Signature of the consent form
* Affiliation to a social security scheme
Exclusion Criteria:
* Severe untreated or unbalanced hypertension
* Preoperative renal failure on dialysis
* Acute heart failure
* Acute coronary insufficiency
* Vascular surgery with renal plasty
* Cardiac surgery
* Permanent laparoscopy
* Chronic respiratory failure with home oxygen therapy
* Acute respiratory distress syndrome with FiO2\>60%.
* Preoperative shock
* Surgery under spinal anaesthesia and epidural only
* Refusal to participate by the patient
* Pregnant, parturient or breastfeeding women
* Patients under guardianship or curators, under court protection or deprived of public rights
* The patient already included in another therapeutic trial with an experimental molecule
* Emergency surgery
* Patients who do not want their personal data to be used in the framework of the research
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05824260
Study Brief:
Protocol Section:
NCT05824260